معرفی
Ralf Bartenschlager is a Professor at the Department of Virology, Medical Faculty of Heidelberg University. His research focuses on viral replication mechanisms, antiviral drug development, and host-pathogen interactions, particularly in hepatitis C virus (HCV), SARS-CoV-2, and other RNA viruses. He has pioneered studies on viral replication organelles, interferon responses, and translational drug candidates like mosnodenvir for dengue virus.
Key contributions include uncovering the role of autophagy in viral exploitation, elucidating HCV NS3-NS4B interactions, and developing assays for SARS-CoV-2 neutralization in immunocompromised patients. His work spans structural virology, molecular biology, and clinical translation, with emphasis on combating emerging pathogens like Zika and coronaviruses.
- Affiliations: Heidelberg University Hospital, German Center for Infection Research (DZIF)
- Research Themes: Viral replication organelles, antiviral inhibitors, host immune responses, drug discovery pipelines
Recent studies highlight his team's exploration of PI4KA enzyme roles in liver cancer, ACE2 activity post-SARS-CoV-2 exposure, and the dynamics of interferon regulatory factors in viral suppression. He collaborates internationally on vaccine efficacy in vulnerable populations (e.g., hemodialysis patients, kidney transplant recipients).
